<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Feb. 21, 2018 (HealthDay News) — The interactive iCanDecide breast cancer treatment decision tool can improve high-quality decision making about breast cancer surgical treatment, according to a study published online Jan. 24 in the Journal of Clinical Oncology<\/i>.<\/p>\n
Sarah T. Hawley, Ph.D., from the University of Michigan in Ann Arbor, and colleagues randomized 537 patients with newly diagnosed, early-stage breast cancer to the iCanDecide interactive and tailored website (intervention) or the iCanDecide static website (control).<\/p>\n
The researchers found that patients in the intervention arm had higher odds of making a high-quality decision versus those in the control arm (odds ratio, 2.00; P = 0.0004). This difference was driven primarily by the rates of high knowledge in the groups. In the intervention arm, more patients had high decision preparation (P = 0.027), but there were no significant differences in the other decision appraisal outcomes. The effect of the intervention was similar for women at enrollment who were leaning strongly toward a treatment option versus with those who were not.<\/p>\n
“To be effective, future patient-facing decision tools should be integrated into the clinical workflow to improve decision making,” the authors write.<\/p>\n
Several authors disclosed financial ties to the diagnostics and pharmaceutical industries.<\/p>\n
Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n